Navigation Links
Amarin's AMR101 Phase 3 ANCHOR Trial Meets all Primary and Secondary Endpoints with Statistically Significant Reductions in Triglycerides at Both 4 Gram and 2 Gram Doses and Statistically Significant Decrease in LDL-C
Date:4/17/2011

cardiovascular risk. Apo B is a sensitive index of residual cardiovascular risk and is generally considered to be a better predictor than LDL-C.  Lp-PLA2 is an enzyme found in blood and atherosclerotic plaque; high levels have been implicated in the development and progression of atherosclerosis. The safety profile of AMR101 was similar to placebo and there were no treatment-related serious adverse events in the trial. These results confirm and build upon the positive results for the MARINE Phase 3 trial announced in November 2010. The Company expects to present more details of these results at an upcoming scientific meeting.

Principal Investigator and Company Very Encouraged by Results

"The design and execution of the ANCHOR trial were robust and the trial results were very clearly positive," said Christie M. Ballantyne, M.D., Methodist DeBakey Heart and Vascular Center, Houston, and principal investigator of the ANCHOR trial.  "I am very impressed with the performance of AMR101. In particular, whereas current triglyceride-lowering drugs may raise LDL-C and causes patient treatment concerns, AMR101 demonstrated a decrease in LDL-C beyond the decrease created by statin therapy. Furthermore, it is very encouraging for patient care that AMR101 caused reductions in significant markers of cardiovascular risk such as Apo B and non-HDL-C. The greater triglyceride reduction in patients with higher potency statin regimens is also very encouraging."  

Commenting on the ANCHOR trial results, Joseph S. Zakrzewski, Chief Executive Officer and Executive Chairman of Amarin, stated, "We are delighted by the results of the ANCHOR trial. In November we announced MARINE trial results which position AMR101 to be best-in-class for treating patients with very high triglycerides. The ANCHOR trial results are even more remarkable than the broadly positive MARINE trial results. We believe these results clearly differentiate AMR101 from other trig
'/>"/>

SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  Pressure BioSciences, Inc. (OTCQB: ... has received and approved all parts required to ... has begun to manufacture the new PCT-based instrument ... be ready for shipment by mid-October and that ... at a rate of about one per week ...
(Date:9/19/2014)... Tenn. , Sept. 19, 2014  Over 200 ... the Future to Benefit the Radiation Oncology Institute (ROI), ... held at Golden Gate Park in San Francisco.  ... Dan Moore , CEO of Radiation Business Solutions, ... we have raised over $70,000 for the ROI this ...
(Date:9/19/2014)... , Sept. 19, 2014  PCI is ... International (Biotec).  Biotec is a leading provider of ... headquartered in Bridgend, Wales ...  The addition significantly expands PCI,s presence in the ... products by adding packaging, storage and distribution capacity, ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
... Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today ... Pharma A/S and Santaris Pharma A/S Corp. in the ... California.  Isis, infringement suit against Santaris is based upon ... services to several pharmaceutical companies.  As alleged in the ...
... London-based technology-driven marketing solutions company U.S. Branding Group, ... they will be participating at DigiPharm Europe, Sept. ... marketing conference for senior pharmaceutical executives. The conference ... enhance online communication, customer relationship, strengthen brand awareness ...
Cached Medicine Technology:Isis Pharmaceuticals Files Patent Infringement Suit Against Santaris Pharma 2Isis Pharmaceuticals Files Patent Infringement Suit Against Santaris Pharma 3U.S. Branding Group Ltd. to Sponsor DigiPharm Europe 2011, Showcase PharmaDrive™ USB Insert™ Paper Webkey 2
(Date:9/20/2014)... Las Vegas, NV (PRWEB) September 21, 2014 ... created by Dr. Kenneth Pullman that is helping thousands ... reverse their diabetes symptoms without shots, pills, or prescriptions ... investigative review. , “There are currently tens of ... with both Type 1 and Type 2 diabetes, and ...
(Date:9/20/2014)... Islands of Loreto, Baja, Mexico (PRWEB) September 20, 2014 ... of Loreto today announced the resort did not experience ... fully operational, with all amenities and activities available. , ... September 14, 2014, bringing intense wind, rain and powerful ... Baja Peninsula, Villa del Palmar Islands of Loreto experienced ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 As ... grow in federal court, Bernstein Liebhard LLP notes ... Administration (FDA) have voted overwhelmingly to recommend that ... men be subjected to further study in order ... report published on September 18th by Bloomberg.com, the ...
(Date:9/20/2014)... The festival season is coming soon. The ... released luxurious cocktail dresses . A lot of sophisticated ... to launch a new promotion for its high quality clothes. ... discounted price, from 20 to 71 percent off. , ... choices. They are provided in many fashionable colors. Mary, the ...
(Date:9/20/2014)... Recently, Best Cheap Hosting USA ... its new website. The new site provides the ... products for customers. Here, people can find a ... decision. Also, it has recommended some excellent web ... of the great web hosting suppliers, InMotion ( ...
Breaking Medicine News(10 mins):Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2
... Treatment after oxygen deprivation accounts for better motor skills ... -- Babies who are deprived of oxygen at birth ... has shown that cooling infants can help prevent problems. ... actually reduces the number of brain lesions in the ...
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), ... http://www.cordblood-america.com ) focused on bringing the ... policy for families nationwide and internationally, today addressed shareholder ... its recently refiled S1 with the SEC, in an ...
... ... almost anyone to sustain life in the first critical minutes of cardiac arrest. ... vital organs alive until professional rescuers arrive. AED (Automated External Defibrillator) is an ... to a normal heartbeat. AEDs are very accurate and easy to use. With ...
... ... in infrared light therapy products, launches the Freedom 300, a new product for the treatment ... World Diabetes Day, 100% of the gross proceeds from sales from the Freedom 300 on ... , ...
... ETEX Corporation, an advanced biomaterials company, announced today ... California. Alphatec Spine will market and sell ETEX,s ... basis in the United States. , (Logo: ... Initial sales and marketing efforts will be focused ...
... The following was released today by Randall Terry: , On ... outside in the hall at Nancy Pelosi,s office, #235 Cannon office ... bill - all 2,000 pages (4,000) - and proceeded to rip ... , Approximately 150 supporters were in the hall, chanting: "Kill the ...
Cached Medicine News:Health News:Cord Blood America Updates Advantages of Las Vegas Laboratory in Analyst Interview; Explains Recent S1 Filing 2Health News:A New Era of E-Learning in the Comfort and Convenience of Your Home or Office Without the Classroom Environment 2Health News:Anodyne Therapy, LLC Develops Device For Treatment of Foot and Leg Pain And Pledges Donation In Honor Of World Diabetes Day 2Health News:Anodyne Therapy, LLC Develops Device For Treatment of Foot and Leg Pain And Pledges Donation In Honor Of World Diabetes Day 3Health News:ETEX Corporation Announces Distribution Agreement with Alphatec Spine 2Health News:ETEX Corporation Announces Distribution Agreement with Alphatec Spine 3
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
... ACCU-Beam® line of Surgical Microscope Accessories includes ... fiber optic cables, and fiberoptic retrofits. TTI ... pat. no. 5,264,928) is the only adaptor ... cameras on the same adaptor body. It ...
Inquire...
... have been optimized to complete the range ... interact in perfect synchronization with the ALLEGRETTO ... and patient parameters are transferred from the ... systems via diskette, mini CD or memory ...
Medicine Products: